Last checked at 
LONDON (Alliance News) - The following AIM-listed companies are making headlines on Alliance News Professional at the market open Friday:
----------
Quindell Portfolio Raises GBP200M Through Share Placing
----------
Bglobal Enters Agreement With Future Energy Solutions For Nutech Training
----------
Northbridge Industrial Services Acquires Assets of Oilfield Material Management For USD3M
----------
Armadale Capital To Buy Rest Of Netcom Global; Deal Gives It 80% Interest In Mpokoto Gold Project
----------
London Capital Finance Director Steps Down; Appoints Interim Finance Chief While It Looks For Successor
----------
Physiomics FY Turnover Up 77% To GBP240,000 Vs GBP135,306; Operating Loss Of GBP548,342 Vs GBP577,922; FY Net Loss Of GBP500,571 Vs GBP539,577; Signed A SEDA Structured Equity Deal, Won A Feasibility Grant
----------
Parkmead Group FY Pretax Loss GBP5.3M Vs GBP4.9M; Revenue Up 38% To GBP4.1 Million; FY Total Assets GBP53.4M Vs GBP22.9M; In Advanced Talks With Debt Lenders
----------
Noricum Gold: Results Continue To Reinforce High Grade Nature Of Rotguloden Project ; Visible Gold Intersected In Drill Hole C9; Drilling On-Going Underground; Looks Forward To Further Positives In Near Future
----------
GW Phamaceuticals Orphan Drug Designation Granted For Epidiolex In Dravet Syndrome By FDA
----------
Touchstone Gold Q3 Net Loss USD499,350 Vs USD2.3M; 9-Mo Net Loss USD16.9M Vs USD7.7M
----------
ValiRx To Raises GBP1M Through Share Placing
----------
Doriemus Reorganises Board, Don Strang New Chairman
----------
Frontier IP Makes New Spin-Out Company With Plymouth University; Receives 21% Stake In New Spin-Out Company PulsiV Solar
----------
Matchtech Chairman: Q1 Trading In Line With Board Expectations; Demand For Contract Recruitment Continues To Grow; Seeing First Signs Of Permanent Candidate Confidence Returning; Q1 Net Fee Income Of GBP11.1M, Up 13%; Looks Forward With Confidence To The Year Ahead
----------
Pantheon Resources FY Loss GBP700,095 Vs GBP703,602
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.
6 Sep 2018 09:05
ValiRx enters 'very exciting' phase for cancer therapies
(Sharecast News) - ValiRx told investors on Thursday that its clinical-stage therapeutics had continued to demonstrate "significant potential" for addressing unmet medical needs in oncology.
Read more